Abiopharma

News list

Director Rollins Brad 🟡 adjusted position in 0 shares (1 derivative) of Usio, Inc. (USIO) at $2.81 Transaction Date: Aug 21, 2026 | Filing ID: 001305

Full text

News bot Aug. 25, 2026, 10:07 p.m.
🔍 Rollins Brad (Director)

Company: Usio, Inc. (USIO)

Report Date: 2026-08-21
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 7,000
- Total shares sold: 7,000
Detailed Transactions and Holdings:
- Acquired 7,000 shares of Common Stock at $2.81 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 150,667.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 7,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2035-08-21 | Exercise: 2026-08-21 | equity_swap_involved: 0 | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: The reporting person received these shares of common stock due to the vesting and subsequent conversion of restricted stock units granted on August 21, 2025, and vested on August 21, 2026.